Jacobs Levy Equity Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Jacobs Levy Equity Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,008,029	Closed	-$8.78M	–	1126
2021 Q3	$8.78M	Sell	1,008,029 -26,037	-3%	-$237K	0.06%	326
2021 Q2	$10.6M	Sell	1,034,066 -134,737	-12%	-$1.42M	0.07%	285
2021 Q1	$14M	Sell	1,168,803 -27,718	-2%	-$314K	0.11%	231
2020 Q4	$10.9M	Buy	1,196,521 +152,599	+15%	+$1.18M	0.1%	243
2020 Q3	$6.36M	Buy	1,043,922 +127,373	+14%	+$972K	0.07%	292
2020 Q2	$8.14M	Buy	916,549 +688,848	+303%	+$5.94M	0.09%	255
2020 Q1	$1.65M	Buy	227,701 +5,962	+3%	+$44.2K	0.02%	524
2019 Q4	$1.96M	Buy	221,739 +54,009	+32%	+$404K	0.02%	548
2019 Q3	$1.02M	Sell	167,730 -700	-0.4%	-$3.93K	0.01%	613
2019 Q2	$704K	Buy	168,430 +17,630	+12%	+$92.9K	0.01%	694
2019 Q1	$949K	Buy	150,800 +47,100	+45%	+$330K	0.01%	673
2018 Q4	$672K	Buy	103,700 +11,600	+13%	+$88.7K	0.01%	681
2018 Q3	$764K	Sell	92,100 -15,100	-14%	-$115K	0.01%	695
2018 Q2	$668K	Buy	107,200 +85,200	+387%	+$542K	0.01%	748
2018 Q1	$151K	Sell	22,000 -61,600	-74%	-$391K	﹤0.01%	954
2017 Q4	$550K	Buy	83,600 +69,300	+485%	+$423K	0.01%	729
2017 Q3	$80K	Buy	+14,300	New	+$96.5K	﹤0.01%	923
2017 Q1	–	Sell	-24,600	Closed	-$266K	–	1039
2016 Q4	$266K	Sell	24,600 -17,051	-41%	-$227K	0.01%	789
2016 Q3	$681K	Sell	41,651 -52,160	-56%	-$734K	0.01%	654
2016 Q2	$894K	Buy	93,811 +53,030	+130%	+$577K	0.02%	619
2016 Q1	$573K	Buy	+40,781	New	+$422K	0.01%	701
2015 Q4	–	Sell	-74,440	Closed	-$507K	–	893
2015 Q3	$507K	Sell	74,440 -8,293	-10%	-$64.2K	0.01%	577
2015 Q2	$755K	Sell	82,733 -5,387	-6%	-$40.8K	0.01%	510
2015 Q1	$595K	Sell	88,120 -33,600	-28%	-$135K	0.01%	564
2014 Q4	$411K	Buy	121,720 +55,712	+84%	+$178K	0.01%	633
2014 Q3	$221K	Sell	66,008 -27,471	-29%	-$85.8K	﹤0.01%	730
2014 Q2	$389K	Buy	93,479 +47,417	+103%	+$251K	0.01%	674
2014 Q1	$365K	Sell	46,062 -54,222	-54%	-$404K	0.01%	722
2013 Q4	$708K	Buy	100,284 +29,133	+41%	+$194K	0.01%	653
2013 Q3	$526K	Buy	71,151 +37,651	+112%	+$293K	0.01%	679
2013 Q2	$291K	Buy	+33,500	New	+$215K	0.01%	832

Other funds holding NPTN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Jacobs Levy Equity Management's NPTN Position: Q4 2021 in Review

Jacobs Levy Equity Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 1,008,029 shares — an estimated $8.78M sold.

Jacobs Levy Equity Management first reported a position in NPTN in Q2 2013 and held it in 31 quarters. The position peaked at $14M in Q1 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

Jacobs Levy Equity Management reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
Jacobs Levy Equity Management sold 1,008,029 NEOPHOTONICS CORP shares in Q4 2021, an estimated $8.78M.
Jacobs Levy Equity Management first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 31 quarters.
Jacobs Levy Equity Management's NEOPHOTONICS CORP position peaked at $14M in Q1 2021.
145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.